Press Features
How ‘Australia’s Angelina Jolie’ Krystal Barter is becoming our most influential philanthropist
She has been referred to as Australia’s Angelina Jolie, but as well as them both carrying the faulty BRCA1 gene, Krystal Barter also shares the Oscar-winner’s influence and star pulling power.
Genetic testing and insurance: I was destined to get cancer, but I don’t deserve discrimination
From the moment I was conceived, I was destined to get cancer. My parents didn’t know it at the time. My family carries the BRCA1 gene fault. More than 20 women in my family have been diagnosed with breast and ovarian cancer.
‘Living in fear’: Decision due on breast implants linked to cancer
“Head to toe, it felt like my body was on fire, my body was literally screaming for me to listen to it,” said Krystal.
To mark Breast Cancer Awareness Month, MGallery and marie claire hosted a special breakfast event
We called on two remarkable women to share their wisdom with us. The first, health activist, author of The Lucky One, and founder of Humanise Health, Krystal Barter, who in her mid-20s after discovering she carried a gene fault called BRCA 1, elected to have a preventative double mastectomy in order to reduce her chance of a cancer diagnosis.
Opinion: 'The dark secret behind genetic testing that is costing Aussies thousands of dollars'
Krystal Barter, a health advocate and CEO of Humanise Health, embodies the struggle between the preventative power of genomics and the fear of discrimination.
Living with the hereditary BRCA gene mutation, Krystal chose to undergo a double mastectomy and hysterectomy, including the removal of her ovaries, to escape the fate that transpired for many women in her family.
Check Your Breasts
We speak to Pink Hope Community’s Krystal Barter about the importance of women finding out if they have dense breast tissue.
‘Cancer won’t wait’: Testing plunges during pandemic lockdown
Cancer testing plummeted during the coronavirus pandemic and is yet to recover to normal levels, prompting fears that thousands of Australians could be missing the window for early diagnosis.
President’s podcast back with some big topics
The latest episodes of Doctorama feature some big names in Australia’s health and health advocacy.
Genomics, Genetic testing, life insurance & other consequences
oining the discussion is Professor David Thomas, CEO of Omico the Australian Genomic Cancer Medicine Centre and Laboratory Head of Genomic Cancer Medicine at the Garvan Institute; Krystal Barter a health activist, author and founder of Humanise Health; and Jessica Chen, Actuary who works in insurance with in-depth knowledge on genetics
Krystal Barter: ‘I’ve no body parts left that society would deem me to be female’
After having a preventative double mastectomy at the age of 25 and her fallopian tubes and one ovary removed to reduce her risk of cancer six years later, Krystal Barter has gone through more surgeries in her 31 years than most would go through in a lifetime, and had hoped that would be it.